Clinical Trial Update: Elements of Adaptive Immunity in Epithelial Ovarian Cancer

View source ↗

Summary

A completed clinical trial update examining elements of adaptive immunity in epithelial ovarian cancer, specifically the high-grade serous subtype.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Serous Ovarian Cancer
• Ovarian Cancer

Snippet

Sponsor: Hellenic Cooperative Oncology Group | Conditions: Epithelial High Grade Serous Ovarian Cancer | Status: COMPLETED